Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Traws Pharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q2 2023
- Shares held
- 1.78M
- −74.0K (−4.0%) vs. Q2 2023
- Total value
- $1.27M
- −$919.4K (−42.0%) vs. Q2 2023
- New holders
- 6
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $5.19M |
| Q1 2026 | 28 | $6.62M |
| Q4 2025 | 22 | $3.86M |
| Q3 2025 | 18 | $2.41M |
| Q2 2025 | 19 | $1.87M |
| Q1 2025 | 19 | $3.98M |
| Q4 2024 | 19 | $10.2M |
| Q3 2024 | 12 | $3.80M |
| Q2 2024 | 30 | $1.36M |
| Q1 2024 | 26 | $1.88M |
| Q4 2023 | 27 | $1.35M |
| Q3 2023 | 28 | $1.27M |
| Q2 2023 | 24 | $2.19M |
| Q1 2023 | 25 | $1.04M |
| Q4 2022 | 29 | $1.01M |
| Q3 2022 | 30 | $1.54M |
| Q2 2022 | 32 | $2.36M |
| Q1 2022 | 28 | $3.60M |
| Q4 2021 | 34 | $6.14M |
| Q3 2021 | 37 | $10.5M |
| Q2 2021 | 24 | $10.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Traws Pharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 708,618 | $504.1K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 248,881 | $177.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 192,858 | $139.2K | 0.00% | +23,357+13.8% | Added |
| Renaissance Technologies LLC | 183,694 | $131.0K | 0.00% | −50,980−21.7% | Reduced |
| Two Sigma Investments, LP | 124,703 | $88.7K | 0.00% | −33,095−21.0% | Reduced |
| Two Sigma Advisers, LP | 94,839 | $67.5K | 0.00% | −48,500−33.8% | Reduced |
| State Street Corp | 52,790 | $38.1K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 30,713 | $22.2K | 0.00% | +30,713 | New |
| Northern Trust Corp | 30,783 | $21.9K | 0.00% | 00.0% | Unchanged |
| Beacon Pointe Advisors, LLC | 28,430 | $20.2K | 0.00% | +130.0% | Added |
| Morgan Stanley | 20,110 | $14.3K | 0.00% | 00.0% | Unchanged |
| Hillcrest Wealth Advisors - NY, LLC | 16,723 | $11.9K | 0.01% | 00.0% | Unchanged |
| Mutual Advisors, LLC | 12,700 | $9.04K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 11,654 | $8.41K | 0.00% | −1,063−8.4% | Reduced |
| Two Sigma Securities, LLC | 10,929 | $7.78K | 0.00% | +10,929 | New |
| Edmond de Rothschild Holding S.A. | 6,666 | $4.74K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,782 | $2.69K | 0.00% | +234+6.6% | Added |
| Group One Trading, L.P. | 1,613 | $1.16K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,004 | $714 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 153 | $109 | 0.00% | +2+1.3% | Added |
| TD Waterhouse Canada Inc. | 120 | $87 | 0.00% | +120 | New |
| UBS Group AG | 63 | $45 | 0.00% | −5,592−98.9% | Reduced |
| Bank of America Corp | 33 | $23 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 33 | $23 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 25 | $18 | 0.00% | +25 | New |
| Qube Research & Technologies Ltd | 3 | $2 | 0.00% | +3 | New |
| Royal Bank of Canada | 207 | $0 | 0.00% | +161+350.0% | Added |
| Simplex Trading, LLC | 107 | $0 | 0.00% | +107 | New |
| Signaturefd, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |